Analyst Price Target is $1.75
▲ +472.83% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for TRxADE HEALTH in the last 3 months. The average price target is $1.75, with a high forecast of $1.75 and a low forecast of $1.75. The average price target represents a 472.83% upside from the last price of $0.31.
Current Consensus is
The current consensus among 1 polled investment analysts is to buy stock in TRxADE HEALTH.
TRxADE HEALTH, Inc. provides an online platform for pharmaceutical purchasers. It owns and operates a business-to-business web-based marketplace focused on the United States pharmaceutical industry. The firm operates a web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories, and services. It also provides state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United States Food and Drug Administration and acts as a technology consultant provider that supports their programming needs and provides research on pharmaceutical pricing and shortages in acute care and retail settings. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.